Insulin Requirements for Basal and Auto-Correction Insulin Delivery in Advanced Hybrid Closed-Loop System: 4193 Days’ Real-World Data of Children in Two Different Age Groups

Article Endocrinology & Metabolism

Glycemic Control in Relation to Technology Use in a Single-Center Cohort of Children with Type 1 Diabetes

Alexandra Sawyer et al.

Summary: The use of CGM technology in T1D patients can significantly improve glycemic control, especially in MDI and pump users. Combining HCL technology with pump and CGM use can achieve optimal HbA1c levels.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Endocrinology & Metabolism

Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users

Julien Da Silva et al.

Summary: The preliminary performance evaluation of the MiniMed 780G system in real-world settings shows that most users are able to achieve good glycemic control and minimize hypoglycemia, indicating the effectiveness of the system.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Endocrinology & Metabolism

5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2021

Summary: The American Diabetes Association's Standards of Medical Care in Diabetes provides clinical practice recommendations, components of diabetes care, treatment goals, and evaluation tools. Effective behavior management and psychological well-being are essential for treatment goals, with diabetes self-management education, medical nutrition therapy, physical activity, smoking cessation counseling, and psychosocial care playing crucial roles. Collaborative person-centered care, guided by shared decision-making, is encouraged after comprehensive medical evaluation, with a focus not only on physical health but also behavioral and mental health outcomes.

DIABETES CARE (2021)

Add to Collection

Review Endocrinology & Metabolism

New closed-loop insulin systems

Charlotte K. Boughton et al.

Summary: Advances in diabetes technologies have led to the development of automated closed-loop insulin delivery systems, which are changing the way type 1 diabetes is managed. This review examines the evidence supporting currently available closed-loop systems and those in development, including DIY systems, as well as the challenges and potential enhancements for clinical adoption.

DIABETOLOGIA (2021)

Add to Collection

Article Endocrinology & Metabolism

Advances in Exercise and Nutrition as Therapy in Diabetes

Michael C. Riddell et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Add to Collection

Article Endocrinology & Metabolism

Patients with Type 1 Diabetes Treated with Insulin Pumps Need Widely Heterogeneous Basal Rate Profiles Ranging from Negligible to Pronounced Diurnal Variability

Anna M. Lindmeyer et al.

Summary: The study found significant differences in basal insulin infusion profiles among type 1 diabetes patients using insulin pump therapy, especially overnight. Despite notable interindividual heterogeneity in the dawn phenomenon, widely different empirically derived basal insulin infusion profiles are appropriate for maintaining plasma glucose concentrations mainly in the target range.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Twenty-Four Hour Fasting (Basal Rate) Tests to Achieve Custom-Tailored, Hour-by-Hour Basal Insulin Infusion Rates in Patients With Type 1 Diabetes Using Insulin Pumps (CSII)

Michael A. Nauck et al.

Summary: The study revealed circadian variations in basal insulin infusion rates throughout the day, with higher rates during dawn and dusk periods. Utilizing 24-hour fasting periods can uncover inappropriate basal insulin infusion rates and help optimize treatment strategies.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism